PharmaTher Holdings Ltd. (OTC:PHRRF – Get Free Report)’s share price was down 6.1% on Friday . The stock traded as low as $0.15 and last traded at $0.16. Approximately 178,931 shares traded hands during trading, an increase of 5% from the average daily volume of 169,752 shares. The stock had previously closed at $0.17.
PharmaTher Trading Down 6.1 %
The company has a 50-day moving average of $0.15 and a 200 day moving average of $0.16.
About PharmaTher
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury.
See Also
- Five stocks we like better than PharmaTher
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Which Wall Street Analysts are the Most Accurate?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
